| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 49,027 |
-
| 90,755 | 77,310 | | Cost of Revenue | 11,741 | 5,891 | 150,089 | 13,629 | | | Gross Profit | 37,286 | (5,891) | (59,334) | 63,681 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,700 | 15,816 | (73,057) | 41,324 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 992 | 955 | 957 | (5,080) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,594 | (22,662) | 12,766 | 27,437 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,690 | (15,652) | 6,005 | (6,005) | | Earnings Before Interest And Taxes | 31,284 | (38,314) | 18,771 | 21,432 | | Interest Expense | 10,848 | 11,299 | 17,943 | 30,296 | | Income Before Tax | 20,436 | (49,613) | 828 | (8,864) | | Income Tax Expense | 7,116 | (19,866) | (371) | (3,280) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,320 | (29,747) | 1,199 | (5,584) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,320 | (29,747) | 1,199 | (5,584) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,320 | ($29,747) | $1,199 | ($5,584) |
|
0.51% Nasdaq 
Income Statement
